Pharmaceutical Problem-Solving Lab

1. First hour: Quarantine the batch and preserve every solution and data record; do not automatically retest.
2. Practical investigation: Review system suitability, sample preparation, reference standard, sequence, instrument log and audit trail, then extend into manufacturing if no assignable laboratory cause is demonstrated.

Decision rule: Invalidation needs a documented scientific cause; otherwise the result remains part of the batch decision.

1. First hour: Hold release, secure samples, apparatus and medium, and review the test sequence.
2. Practical investigation: Connect the result to particle size, granulation, compression, hardness, coating, moisture and medium age; do not confine the investigation to the laboratory.

Decision rule: A repeat does not erase the first result; integrate laboratory, manufacturing and process history.

1. First hour: Segregate it, obtain the full time–temperature–location record and avoid immediate rejection or acceptance.
2. Practical investigation: Compare exposure with supporting stability data, verify logger accuracy and placement, packaging integrity and the transport route.

Decision rule: The decision is product-, duration- and temperature-specific; it is not a universal rule.

1. First hour: Stop the affected activity, preserve isolates and records, and define the time and product scope.
2. Practical investigation: Map interventions, operators, trends, filters, cleaning and barrier integrity to determine whether control was lost.

Decision rule: Patient safety drives the hold, recall and requalification decision.

1. First hour: Reopen effectiveness review and link cases rather than creating an isolated record.
2. Practical investigation: Challenge the root-cause hypothesis, action design, ownership, effectiveness measure and timing; examine system, culture and workload drivers.

Decision rule: Administrative closure is not effectiveness; evidence is sustained risk reduction or recurrence prevention.

1. First hour: Preserve the system and backups, restrict access if needed and do not recreate replacement data.
2. Practical investigation: Review accounts, privileges, timestamps, metadata, prior reviews and the product scope affected.

Decision rule: Treat this as a data-quality and product-impact issue, not a minor documentation error.

1. First hour: Do not use the material before impact assessment and any required approval.
2. Practical investigation: Compare process, specifications, impurity profile, source file, GMP status, comparability and stability, then map variation type by market.

Decision rule: Submission and implementation differ by jurisdiction; build a decision matrix before supply.

1. First hour: Assign one owner, freeze the reference version and build a claim–evidence–owner–deadline table.
2. Practical investigation: Separate available evidence, new analysis and future commitment; reconcile the response with the submitted dossier and primary source.

Decision rule: Do not cover an evidence gap with confident prose; state the limit and completion plan.

1. First hour: Check case quality, seriousness, expectedness and duplication, and open a documented signal assessment.
2. Practical investigation: Review exposure, temporal relationship, dechallenge/rechallenge, mechanism, susceptible groups, literature and regulatory databases.

Decision rule: A signal is not confirmed causality, but it requires proportionate action, monitoring and escalation.

1. First hour: Calculate stock, days of cover, open orders and affected products and patients.
2. Practical investigation: Activate a qualified alternative, assess quality and regulatory change risk, and plan allocation and communication.

Decision rule: Do not bypass qualification or quality to move faster; use a controlled change pathway.

1. First hour: Verify medicine, dose, timing, organ function and clinical context, then communicate through the authorised professional pathway.
2. Practical investigation: Use a reliable interaction source, evaluate evidence, alternatives and monitoring, and document the agreed recommendation.

Decision rule: This learning tool does not make a patient-specific decision; that remains with the licensed clinical team.

1. First hour: Do not choose a new analysis after seeing the outcome; lock the database and original analysis plan.
2. Practical investigation: Review deviations, variability, BLQ handling, dosing, sampling, bioanalysis, power and design validity.

Decision rule: A repeat study needs scientific justification and correction of the cause; acceptable results cannot be cherry-picked.